Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucius A Howell

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Expert Review of Clinical Pharmacology|June 21, 2015
Review of clopidogrel dose escalation in the current era of potent P2Y12 inhibitorsLucius A Howell, George A Stouffer, Melissa Polasek, et al.
The American Journal of Cardiology|December 5, 2017
Relation of an Echocardiographic-Based Cardiac Calcium Score to Mitral Stenosis Severity and Coronary Artery Disease in Patients with Severe Aortic StenosisSiyuan P Sheng, Lucius A Howell, Melissa C Caughey, et al.
Proceedings (Baylor University. Medical Center)|April 2, 2013
Persistent giant U wave inversion with anoxic brain injuryMatthew N Peters, Morgan J Katz, Lucius A Howell, et al.
Proceedings (Baylor University. Medical Center)|July 2, 2013
Coronary angiographic significance of hyperacute ST-T changes associated with regadenoson stressMatthew N Peters, Onita Bhattasli, Andrew R Burchett, et al.
Pharmacogenomics|April 1, 2015
Implementation and evaluation of a CYP2C19 genotype-guided antiplatelet therapy algorithm in high-risk coronary artery disease patientsJohn Andrew Lee, Craig R Lee, Brent N Reed, et al.
Circulation. Genomic and Precision Medicine|April 5, 2018
Clinical Outcomes and Sustainability of Using <i>CYP2C19</i> Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary InterventionCraig R Lee, Vindhya B Sriramoju, Alexandra Cervantes, et al.
JACC. Cardiovascular Interventions|November 6, 2017
Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary InterventionLarisa H Cavallari, Craig R Lee, Amber L Beitelshees, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Expert Review of Clinical Pharmacology|June 21, 2015
Review of clopidogrel dose escalation in the current era of potent P2Y12 inhibitorsLucius A Howell, George A Stouffer, Melissa Polasek, et al.
The American Journal of Cardiology|December 5, 2017
Relation of an Echocardiographic-Based Cardiac Calcium Score to Mitral Stenosis Severity and Coronary Artery Disease in Patients with Severe Aortic StenosisSiyuan P Sheng, Lucius A Howell, Melissa C Caughey, et al.
Proceedings (Baylor University. Medical Center)|April 2, 2013
Persistent giant U wave inversion with anoxic brain injuryMatthew N Peters, Morgan J Katz, Lucius A Howell, et al.
Proceedings (Baylor University. Medical Center)|July 2, 2013
Coronary angiographic significance of hyperacute ST-T changes associated with regadenoson stressMatthew N Peters, Onita Bhattasli, Andrew R Burchett, et al.
Pharmacogenomics|April 1, 2015
Implementation and evaluation of a CYP2C19 genotype-guided antiplatelet therapy algorithm in high-risk coronary artery disease patientsJohn Andrew Lee, Craig R Lee, Brent N Reed, et al.
Circulation. Genomic and Precision Medicine|April 5, 2018
Clinical Outcomes and Sustainability of Using <i>CYP2C19</i> Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary InterventionCraig R Lee, Vindhya B Sriramoju, Alexandra Cervantes, et al.
JACC. Cardiovascular Interventions|November 6, 2017
Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary InterventionLarisa H Cavallari, Craig R Lee, Amber L Beitelshees, et al.
Pageof 1